Anyone prescribed more than one SABA inhaler device a month should be identified and their asthma should be assessed urgently, and steps taken to improve asthma control if this is poor.
Patients who request that ‘just their reliever’ is dispensed should be advised of the importance of using their preventer, and to talk to their GP practice.
Whenever a patient has a new inhaler prescribed, the pharmacist should ensure that they know how to use it. Inhalers should be prescribed – and dispensed – by brand to ensure that patients are not given an inhaler they do not know how to use.1
Pearson MG, Bucknall CE, editors. Measuring clinical outcome in asthma: a patient-focused approach. London: Royal College of Physicians of London; 1999
You are now leaving www.nappacademy.co.uk.
Napp Pharmaceuticals Limited does not accept any responsibility for the content of third-party websites.
